Ni et al. reported on the temporary depletion of donor CD4+ T-cells immediately after allo-HSCT using a single dose of human anti-CD4 monoclonal antibody IT1208, currently under clinical investigation for treatment of advanced solid tumors and in vivo murine leukemia and lymphoma models. This evidence concerns the gene CD4 and leukemia.